Wed 26 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| DICLOFENAC POTASSIUM | DICLOPID 50 mg film-coated tablet | 50 | 12.40 | Details | |
| VALPROATE SODIUM | VALPOHARDT 100 mg/ml solution for injection or infusion | 100 | 246.1 | Details | |
| ACETYLSALICYLIC ACID | ASPIRIN PROTECT 100MG E.C. TABLETS | 100 | 19.05 | Details | |
| DULOXETINE | MODEXA 60 mg gastro-resistant capsule | 60 | 80.25 | Details | |
| CIPROFLOXACIN | CIPROGRAM 750 mg film-coated tablet | 750 | 75.00 | Details | |
| IMIGLUCERASE | CEREZYME 400 U powder for concentrate for solution for infusion | 400 | 5984.85 | Details | |
| ROPINIROLE | REQUIP PD 24HOUR 8 mg prolonged release tablet | 8 | 109.6 | Details | |
| VORICONAZOLE | VFONAZ 200 mg film-coated tablet | 200 | 2334.30 | Details | |
| VORICONAZOLE | VFONAZ 200 mg powder for solution for infusion | 200 | 295.00 | Details | |
| QUETIAPINE | REZAL XR 50 mg extended-release tablet | 50 | 37.55 | Details | |
| QUETIAPINE | REZAL XR 200 mg extended-release tablet | 200 | 122.95 | Details | |
| QUETIAPINE | REZAL XR 300 mg extended-release tablet | 300 | 162.85 | Details | |
| DIOSMIN | PHLEBODIA 600 mg film-coated tablet | 600 | 41.6 | Details | |
| SILDENAFIL | VEGA 50 mg film-coated tablet | 50 | 43.7 | Details | |
| CLARITHROMYCIN | KLARE 500 mg film-coated tablet | 500 | 46.05 | Details | |
| CANDESARTAN CILEXETIL | CANDAN 16 mg tablet | 16 | 45.85 | Details | |
| CANDESARTAN CILEXETIL,HYDROCHLOROTHIAZIDE | CANDAN PLUS 16/12.5 mg tablet | 16,12.5 | 51.35 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 40 mg tablet | 40 | 65.2 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 80 mg tablet | 80 | 97.85 | Details | |
| TADALAFIL | SNAFI 20MG TAB | 20 | 133.4 | Details |
5.17% of users said yes from 174 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.